Ark Therapeutics gears up its infrastructure for Cerepro
This article was originally published in Scrip
Executive Summary
Ark Therapeutics is preparing for the launch of Cerepro (stimagene ceradenovec) ahead of a European approval decision, which is expected at the end of this year.